Skip to main content
. 2017 Sep 1;7(9):1884–1898.

Figure 4.

Figure 4

ZWM026 potently and selectively inhibits growths of several different NSCLC cells. ZWM026 inhibits growths in various tumor cell lines, including NSCLC cells with EGFR-mutant and EGFR-WT, as well as some normal cell lines. Cell viability was analyzed using MTT assay after 72 hours of treatment. The data are expressed as mean ± SD from three or more independent experiments.